Renivace and blood alkaline phosphatase increased Patient Reports February 13, 2012

Renivace Side Effects Report #4767736-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 25, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy  and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, dysuria, eosinophil percentage decreased, gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4775021-X
Renivace side effect was reported by a Physician from JAPAN on Sept 02, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy  and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, dysuria, eosinophil percentage decreased, epilepsy , gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4796542-X
Renivace side effect was reported by a Physician from JAPAN on Sept 21, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy , gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, cystitis, dysuria, epilepsy , gamma-glutamyltransferase increased, nocturia. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, AMLODIPINE BESYLATE, CLARITIN, MAGMITT, NORVASC. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4952120-0
Renivace side effect was reported by a Physician from JAPAN on Mar 02, 2006. Male patient, 77 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: blood aldosterone decreased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, creatinine renal clearance decreased, eosinophil percentage increased, hyperkalaemia, hyponatraemia. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with DILTIAZEM, ASPIRIN, MAGNESIUM OXIDE, FORSENID, GASTER D, ANTIBIOTIC, PHYSIOLOGICAL SALINE. Patient recovered.


Renivace Side Effects Report #4984370-1
Renivace side effect was reported by a Physician from JAPAN on Apr 04, 2006. Male patient, 77 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: blood aldosterone decreased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, carcinoembryonic antigen increased, condition aggravated, creatinine renal clearance decreased, eosinophil percentage increased. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with DILTIAZEM, ASPIRIN, MAGNESIUM OXIDE, FORSENID, GASTER D, ANTIBIOTIC, PHYSIOLOGICAL SALINE. Patient recovered.

Renivace Side Effects Report #5143257-4
Renivace side effect was reported by a Physician from JAPAN on Oct 13, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with hypertension, gastric ulcer, gastric ulcer haemorrhage, sepsis , angina pectoris, myocardial infarction and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gastric ulcer haemorrhage, hepatic infiltration eosinophilic, liver disorder. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with FAMOTIDINE, GASTER D, PAZUCROSS, PANALDINE, ARTIST, ASPIRIN, SIGMART. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5085260-9
Renivace side effect was reported by a Physician from ALBANIA on July 31, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5102516-1
Renivace side effect was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with hypertension, angina pectoris, coronary arterial stent insertion, hyperlipidaemia, hypertonia and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test positive. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with PANALDINE, LIVALO, SIGMART, CALBLOCK, ARTIST. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5050441-7
Renivace side effect was reported by a Physician from JAPAN on June 21, 2006. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil percentage decreased, face oedema. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #4705683-4
Renivace side effect was reported by a Physician from on June 10, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil percentage decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, HERBERSSER R. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4717263-5
Renivace side effect was reported by a Physician from JAPAN on June 29, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dysphonia, eosinophil percentage decreased, gamma-glutamyltransferase increased, laryngeal oedema. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4733538-8
Renivace side effect was reported by a Physician from JAPAN on July 13, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil count decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4746491-8
Renivace side effect was reported by a Physician from JAPAN on July 29, 2005. Male patient, 53 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angioneurotic oedema, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease recurrence, dysphonia, eosinophil count decreased, gamma-glutamyltransferase increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with ASPIRIN, MARZULENE S, DILTIAZEM. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4715569-7
Renivace side effect was reported by a Physician from JAPAN on June 27, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, aspartate aminotransferase increased, beta-n-acetyl-d-glucosaminidase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic decreased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.


Renivace Side Effects Report #4737007-0
Renivace side effect was reported by a Physician from JAPAN on July 21, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.

Renivace Side Effects Report #4757799-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 12, 2005. Female patient, 80 years of age, was diagnosed with nocturia, insomnia, epilepsy  and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil count decreased, blood alkaline phosphatase increased, dysuria, eosinophil count decreased, gamma-glutamyltransferase increased, lymphocyte count increased, monocyte count decreased, neutrophil count decreased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4751681-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 05, 2005. Male patient, 70 years of age, was treated with Renivace. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, c-reactive protein increased, gamma-glutamyltransferase increased, pancytopenia. Renivace dosage: unknown. During the same period patient was treated with GASTER D, PANALDINE, ADALAT, ASPIRIN, CARDENALIN, LAXOBERON, NITOROL, SELOKEN. Patient was hospitalized. Patient recovered.